Yan Wei

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Acute Ischemic Stroke

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)
Shuya Li, Xuechun Wang, Aoming Jin, Gaifen Liu, Hong-Qiu Gu, Hao Li, Bruce C V Campbell, Marc Fisher, Yi Yang, Yan Wei, Junhai Wang, Yilong Wang, Xing-Quan Zhao, Li-Ping Liu, Zi-Xiao Li, Xia Meng, Yong-Jun Wang
Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. Stroke 55 (2) (2023)